Moderna's 2022 Windfall a 'Scandalous' Result of Pandemic Profiteering, Campaigners Say
One advocate said Moderna's windfall was a "direct result of the company’s refusal to share vaccine technology with the Global South, even when it was clear that global shortages would be deadly."
The Massachusetts-based pharmaceutical giant Moderna announced Thursday that it brought in over $19 billion in revenue and $8.4 billion in profits in 2022 thanks primarily to its Covid-19 vaccine, which was made possible by federal funding and government technology.
"U.S. taxpayers and people all over the world should be furious," Maaza Seyoum, Global South convenor of the People's Vaccine Alliance, said in response to Moderna's earnings report. "It was built on decades of publicly funded research into mRNA vaccines. And it was developed in partnership with the U.S. National Institutes of Health. This should be the people's vaccine, available and affordable to everyone, everywhere, not a goldmine for Big Pharma."
“Moderna's revenue in 2022 alone is equivalent to the combined health budgets of 68 countries," Seyoum noted. "Already, the company expects to make more from the vaccine in 2023 than the combined health budgets of 42 countries." As CNBC reported, "Moderna has contracts on the books for $5 billion in Covid vaccine deliveries for 2023."
Moderna sold $18.4 billion worth of its coronavirus vaccine—the company's only product on the market—last year while rejecting calls to share critical technology with the rest of the world, denying low-income countries the ability to quickly produce lifesaving shots for their populations.
Tim Bierley, a pharma campaigner at the U.K.-based advocacy group Global Justice Now, said Thursday that "history will not be kind to Moderna, whose scandalous profits are a direct result of the company's refusal to share vaccine technology with the Global South, even when it was clear that global shortages would be deadly."
"Millions of people around the world are now grieving the loss of family members, many of whom were unable to get a Covid-19 vaccine," said Bierley. "Moderna's pandemic profiteering is even more shocking given that the U.S. public-funded 100% of this vaccine's development. Now the company is brazenly threatening to hike prices on its vaccine—but governments should refuse to be held to ransom. And well before the next pandemic, we must make sure that taxpayer money comes with conditions that put lives above profits."
Moderna's earnings announcement came weeks after the company sparked widespread backlash by proposing to hike the U.S. price of its coronavirus vaccine by 4,000% over the cost of production.
Among those who condemned the planned price hike was Sen. Bernie Sanders of Vermont, who has used his platform as chair of the Senate Health, Education, Labor, and Pensions Committee to call out Moderna and other pharmaceutical giants for exploiting health crises to pad their bottom lines.
Shortly after Sanders announced last week that he intends to grill Moderna's billionaire CEO on the vaccine price during a Senate hearing next month, the company said it would ensure its shot remains available for free in the U.S.
"This is an astounding reversal, entirely due to Bernie Sanders preparing to make Moderna a poster child of corporate greed, along with the public organizing against the company," said Robert Weissman, president of the consumer advocacy group Public Citizen.
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just four days to go in our Spring Campaign, we are not even halfway to our goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
The Massachusetts-based pharmaceutical giant Moderna announced Thursday that it brought in over $19 billion in revenue and $8.4 billion in profits in 2022 thanks primarily to its Covid-19 vaccine, which was made possible by federal funding and government technology.
"U.S. taxpayers and people all over the world should be furious," Maaza Seyoum, Global South convenor of the People's Vaccine Alliance, said in response to Moderna's earnings report. "It was built on decades of publicly funded research into mRNA vaccines. And it was developed in partnership with the U.S. National Institutes of Health. This should be the people's vaccine, available and affordable to everyone, everywhere, not a goldmine for Big Pharma."
“Moderna's revenue in 2022 alone is equivalent to the combined health budgets of 68 countries," Seyoum noted. "Already, the company expects to make more from the vaccine in 2023 than the combined health budgets of 42 countries." As CNBC reported, "Moderna has contracts on the books for $5 billion in Covid vaccine deliveries for 2023."
Moderna sold $18.4 billion worth of its coronavirus vaccine—the company's only product on the market—last year while rejecting calls to share critical technology with the rest of the world, denying low-income countries the ability to quickly produce lifesaving shots for their populations.
Tim Bierley, a pharma campaigner at the U.K.-based advocacy group Global Justice Now, said Thursday that "history will not be kind to Moderna, whose scandalous profits are a direct result of the company's refusal to share vaccine technology with the Global South, even when it was clear that global shortages would be deadly."
"Millions of people around the world are now grieving the loss of family members, many of whom were unable to get a Covid-19 vaccine," said Bierley. "Moderna's pandemic profiteering is even more shocking given that the U.S. public-funded 100% of this vaccine's development. Now the company is brazenly threatening to hike prices on its vaccine—but governments should refuse to be held to ransom. And well before the next pandemic, we must make sure that taxpayer money comes with conditions that put lives above profits."
Moderna's earnings announcement came weeks after the company sparked widespread backlash by proposing to hike the U.S. price of its coronavirus vaccine by 4,000% over the cost of production.
Among those who condemned the planned price hike was Sen. Bernie Sanders of Vermont, who has used his platform as chair of the Senate Health, Education, Labor, and Pensions Committee to call out Moderna and other pharmaceutical giants for exploiting health crises to pad their bottom lines.
Shortly after Sanders announced last week that he intends to grill Moderna's billionaire CEO on the vaccine price during a Senate hearing next month, the company said it would ensure its shot remains available for free in the U.S.
"This is an astounding reversal, entirely due to Bernie Sanders preparing to make Moderna a poster child of corporate greed, along with the public organizing against the company," said Robert Weissman, president of the consumer advocacy group Public Citizen.
The Massachusetts-based pharmaceutical giant Moderna announced Thursday that it brought in over $19 billion in revenue and $8.4 billion in profits in 2022 thanks primarily to its Covid-19 vaccine, which was made possible by federal funding and government technology.
"U.S. taxpayers and people all over the world should be furious," Maaza Seyoum, Global South convenor of the People's Vaccine Alliance, said in response to Moderna's earnings report. "It was built on decades of publicly funded research into mRNA vaccines. And it was developed in partnership with the U.S. National Institutes of Health. This should be the people's vaccine, available and affordable to everyone, everywhere, not a goldmine for Big Pharma."
“Moderna's revenue in 2022 alone is equivalent to the combined health budgets of 68 countries," Seyoum noted. "Already, the company expects to make more from the vaccine in 2023 than the combined health budgets of 42 countries." As CNBC reported, "Moderna has contracts on the books for $5 billion in Covid vaccine deliveries for 2023."
Moderna sold $18.4 billion worth of its coronavirus vaccine—the company's only product on the market—last year while rejecting calls to share critical technology with the rest of the world, denying low-income countries the ability to quickly produce lifesaving shots for their populations.
Tim Bierley, a pharma campaigner at the U.K.-based advocacy group Global Justice Now, said Thursday that "history will not be kind to Moderna, whose scandalous profits are a direct result of the company's refusal to share vaccine technology with the Global South, even when it was clear that global shortages would be deadly."
"Millions of people around the world are now grieving the loss of family members, many of whom were unable to get a Covid-19 vaccine," said Bierley. "Moderna's pandemic profiteering is even more shocking given that the U.S. public-funded 100% of this vaccine's development. Now the company is brazenly threatening to hike prices on its vaccine—but governments should refuse to be held to ransom. And well before the next pandemic, we must make sure that taxpayer money comes with conditions that put lives above profits."
Moderna's earnings announcement came weeks after the company sparked widespread backlash by proposing to hike the U.S. price of its coronavirus vaccine by 4,000% over the cost of production.
Among those who condemned the planned price hike was Sen. Bernie Sanders of Vermont, who has used his platform as chair of the Senate Health, Education, Labor, and Pensions Committee to call out Moderna and other pharmaceutical giants for exploiting health crises to pad their bottom lines.
Shortly after Sanders announced last week that he intends to grill Moderna's billionaire CEO on the vaccine price during a Senate hearing next month, the company said it would ensure its shot remains available for free in the U.S.
"This is an astounding reversal, entirely due to Bernie Sanders preparing to make Moderna a poster child of corporate greed, along with the public organizing against the company," said Robert Weissman, president of the consumer advocacy group Public Citizen.